Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>

Group A <i>Streptococcus</i> (GAS) causes a variety of diseases globally. The DNases in GAS promote GAS evasion of neutrophil killing by degrading neutrophil extracellular traps (NETs). Sda1 is a prophage-encoded DNase associated with virulent GAS strains. However, protective immunity ag...

Full description

Bibliographic Details
Main Authors: Shuai Bi, Jie Wang, Meiyi Xu, Ning Li, Beinan Wang
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/1/102
_version_ 1797489863972356096
author Shuai Bi
Jie Wang
Meiyi Xu
Ning Li
Beinan Wang
author_facet Shuai Bi
Jie Wang
Meiyi Xu
Ning Li
Beinan Wang
author_sort Shuai Bi
collection DOAJ
description Group A <i>Streptococcus</i> (GAS) causes a variety of diseases globally. The DNases in GAS promote GAS evasion of neutrophil killing by degrading neutrophil extracellular traps (NETs). Sda1 is a prophage-encoded DNase associated with virulent GAS strains. However, protective immunity against Sda1 has not been determined. In this study, we explored the potential of Sda1 as a vaccine candidate. Sda1 was used as a vaccine to immunize mice intranasally. The effect of anti-Sda1 IgG in neutralizing degradation of NETs was determined and the protective role of Sda1 was investigated with intranasal and systemic challenge models. Antigen-specific antibodies were induced in the sera and pharyngeal mucosal site after Sda1 immunization. The anti-Sda1 IgG efficiently prevented degradation of NETs by supernatant samples from different GAS serotypes with or without Sda1. Sda1 immunization promoted clearance of GAS from the nasopharynx independent of GAS serotypes but did not reduce lethality after systemic GAS challenge. Anti-Sda1 antibody can neutralize degradation of NETs by Sda1 and other phage-encoded DNases and decrease GAS colonization at the nasopharynx across serotypes. These results indicate that Sda1 can be a potential vaccine candidate for reduction in GAS reservoir and GAS tonsillitis-associated diseases.
first_indexed 2024-03-10T00:22:42Z
format Article
id doaj.art-534f3703f48e4e49af1f0a11be4c46ca
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T00:22:42Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-534f3703f48e4e49af1f0a11be4c46ca2023-11-23T15:39:28ZengMDPI AGVaccines2076-393X2022-01-0110110210.3390/vaccines10010102Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>Shuai Bi0Jie Wang1Meiyi Xu2Ning Li3Beinan Wang4Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaGroup A <i>Streptococcus</i> (GAS) causes a variety of diseases globally. The DNases in GAS promote GAS evasion of neutrophil killing by degrading neutrophil extracellular traps (NETs). Sda1 is a prophage-encoded DNase associated with virulent GAS strains. However, protective immunity against Sda1 has not been determined. In this study, we explored the potential of Sda1 as a vaccine candidate. Sda1 was used as a vaccine to immunize mice intranasally. The effect of anti-Sda1 IgG in neutralizing degradation of NETs was determined and the protective role of Sda1 was investigated with intranasal and systemic challenge models. Antigen-specific antibodies were induced in the sera and pharyngeal mucosal site after Sda1 immunization. The anti-Sda1 IgG efficiently prevented degradation of NETs by supernatant samples from different GAS serotypes with or without Sda1. Sda1 immunization promoted clearance of GAS from the nasopharynx independent of GAS serotypes but did not reduce lethality after systemic GAS challenge. Anti-Sda1 antibody can neutralize degradation of NETs by Sda1 and other phage-encoded DNases and decrease GAS colonization at the nasopharynx across serotypes. These results indicate that Sda1 can be a potential vaccine candidate for reduction in GAS reservoir and GAS tonsillitis-associated diseases.https://www.mdpi.com/2076-393X/10/1/102group A <i>streptococcus</i>DNasesSda1neutrophil extracellular trapspharyngeal colonization
spellingShingle Shuai Bi
Jie Wang
Meiyi Xu
Ning Li
Beinan Wang
Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
Vaccines
group A <i>streptococcus</i>
DNases
Sda1
neutrophil extracellular traps
pharyngeal colonization
title Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
title_full Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
title_fullStr Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
title_full_unstemmed Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
title_short Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
title_sort immunity to sda1 protects against infection by sda1 sup sup and sda1 sup sup serotypes of group a i streptococcus i
topic group A <i>streptococcus</i>
DNases
Sda1
neutrophil extracellular traps
pharyngeal colonization
url https://www.mdpi.com/2076-393X/10/1/102
work_keys_str_mv AT shuaibi immunitytosda1protectsagainstinfectionbysda1supsupandsda1supsupserotypesofgroupaistreptococcusi
AT jiewang immunitytosda1protectsagainstinfectionbysda1supsupandsda1supsupserotypesofgroupaistreptococcusi
AT meiyixu immunitytosda1protectsagainstinfectionbysda1supsupandsda1supsupserotypesofgroupaistreptococcusi
AT ningli immunitytosda1protectsagainstinfectionbysda1supsupandsda1supsupserotypesofgroupaistreptococcusi
AT beinanwang immunitytosda1protectsagainstinfectionbysda1supsupandsda1supsupserotypesofgroupaistreptococcusi